In another such trial (VALUE), researchers randomized 15,245 hypertensive patients (minimum age, 50; mean BP, 155/87 mm Hg) in 31 countries to receive the angiotensin-receptor blocker valsartan or ...

For the duration of trial 1, 61.0% of patients received valsartan alone, whereas 39.0% received additional antihypertensive agents at some point during the study. In trial 2, 75.8% of patients ...

默克（Merck & Co.）3月承诺在2028年前在美投资80亿美元，强生则承诺未来4年投入超过550亿美元。 （吉隆坡15日讯）Novartis制药公司今日澄清，国内市场含有Valsartan原料药的产品不受部分国家的产品召回事件影响。 该公司发表文告指出，尽管日前媒体报道23国家发生 ...